OmniAb (OABI) Current Assets (2021 - 2026)
OmniAb (OABI) reported Current Assets of $65.1 million for Q1 2026, up 21.55% year-over-year from $53.6 million in Q1 2025, and little changed quarter-over-quarter from $65.3 million in Q4 2025.
OmniAb (OABI) Current Assets (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Current Assets data on file, last reported at $65.1 million in Q1 2026.
- Current Assets for Q1 2026 came in at $65.1 million, up 21.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.1 million (up 21.55% YoY), and the FY2025 annual result was $65.3 million, down 4.1% from the prior year.
- Current Assets held at $65.1 million in Q1 2026 per OABI's latest filing, from $65.3 million in the prior quarter.
- Over five years, Current Assets peaked at $125.0 million in Q4 2022 and troughed at $423868.0 in Q3 2022.
- A 5-year average of $67.2 million and a median of $66.6 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets plunged 65.88% in 2022, then surged 25107.85% in 2023.
- A 5-year view of Current Assets shows it stood at $125.0 million in 2022, then slipped by 24.05% to $94.9 million in 2023, then slipped by 28.2% to $68.1 million in 2024, then dropped by 4.1% to $65.3 million in 2025, then decreased by 0.33% to $65.1 million in 2026.
- Business Quant data shows OABI's Current Assets at $65.1 million in Q1 2026, $65.3 million in Q4 2025, and $66.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 65.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.13 Mn |
| Dec 31, 2025 | 65.34 Mn |
| Sep 30, 2025 | 66.35 Mn |
| Jun 30, 2025 | 47.62 Mn |
| Mar 31, 2025 | 53.58 Mn |
| Dec 31, 2024 | 68.14 Mn |
| Sep 30, 2024 | 66.61 Mn |
| Jun 30, 2024 | 67.30 Mn |
| Mar 31, 2024 | 76.72 Mn |
| Dec 31, 2023 | 94.90 Mn |
| Sep 30, 2023 | 106.85 Mn |
| Jun 30, 2023 | 115.94 Mn |
| Mar 31, 2023 | 121.08 Mn |
| Dec 31, 2022 | 124.95 Mn |
| Sep 30, 2022 | 423,868.00 |
| Jun 30, 2022 | 692,011.00 |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 22.54 Mn |
| Sep 30, 2021 | 1.24 Mn |